A new Cochrane review finds that following a low glycemic index diet helps people with type 1 and type 2 diabetes to improve their blood glucose (blood sugar) control significantly ...
WASHINGTON, Dec 17 - Drug companies need to more thoroughly study potential heart-related risks of new diabetes medicines before they reach the market, U.S. health officials said on Wednesday. The decision will mean longer, larger...
NEW ORLEANS, Nov 10 - More expensive drug-coated stents were more effective in reducing the risk of repeat surgical procedures, heart attack and death compared with older bare metal stents in patients with diabetes, according...
TOKYO, Aug 28 - Takeda Pharmaceutical, Japan's largest drugmaker, said on Friday it is set to start an additional clinical study on a key diabetes drug candidate next month, setting a timeline that could see...
WASHINGTON, July 31 - AstraZeneca PLC and Bristol-Myers Squibb Co won U.S. approval on Friday to sell a new diabetes drug called Onglyza. The Food and Drug Administration said it was requiring a post-approval study...
*Allergy drugs reversed diabetes symptoms *Studies all find immune cells out of sync in body fat HONG KONG, July 27 - Over-the-counter allergy and asthma drugs helped obese, diabetic mice lose weight and control their...
* Syncria shows promise in Phase II clinical trial * No sign of thyroid cancer problems in monkey tests * Glaxo embarked on 2-3 years Phase III programme LONDON, June 7 - An experimental diabetes...
* 58 pct at target blood sugar level vs 37 pct * 2.7 kg weight loss vs 1.1 kg weight gain NEW YORK, June 7 - Novo Nordisk A/S's experimental diabetes drug liraglutide was significantly...
CHICAGO, April 14 - People with type 1 diabetes who got stem cell transplants were able to go as long as four years without needing insulin treatments, U.S. researchers said on Tuesday. They said the...
SILVER SPRING, Md., April 2 - A U.S. advisory panel was divided on Thursday over whether tumors that developed in rodents during testing of Novo Nordisk experimental diabetes drug makes it too risky for people....